Steffen Brunst - Concepedia

Author

Steffen Brunst

Goethe University Frankfurt

Also Known As

S. Brunst, Steffen Brunst

Publications

259

Citations

H-Index

Concepts

All Affiliations

Goethe University Frankfurt University Hospital Frankfurt Fraunhofer Institute for Translational Medicine and Pharmacology Fraunhofer Institute for Molecular Biology and Applied Ecology Saarland University

About

Steffen Brunst is an author at Goethe University Frankfurt specializing in drug discovery, medicinal chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	47
2	Natural Sciences	2	2	30
3	Biochemistry	2	2	30
4	Chemical Biology	2	2	30
5	Immunology	1	1	18

Steffen Brunst

Publications

195

Citations

H-Index

Page 1

	Year	Citations
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain Jan S. Kramer, Stefano Woltersdorf, Thomas Duflot, Journal of Medicinal Chemistry	2019	43
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors Felix F. Lillich, Sabine Willems, Xiaomin Ni, Journal of Medicinal Chemistry	2021	28
Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics Moritz Helmstädter, Astrid Kaiser, Steffen Brunst, Journal of Medicinal Chemistry	2021	22
<i>N</i>-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases Cansu Kaya, Jelena Konstantinović, Andreas M. Kany, Journal of Medicinal Chemistry	2022	19
Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase Kerstin Hiesinger, Jan S. Kramer, Sandra Beyer, Journal of Medicinal Chemistry ImmunologyRenal InflammationPharmacotherapyChemical BiologyPharmaceutical Chemistry	2020	18
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases Anna Proschak, Giada Martinelli, Denia Frank, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineAntibacterial AgentAntimicrobial ChemotherapyAntimicrobial Compound	2021	17
<i>N</i>-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from <i>Pseudomonas aeruginosa</i> Samir Yahiaoui, Katrin Voos, Jörg Haupenthal, RSC Medicinal Chemistry	2021	13
Systematic Assessment of Fragment Identification for Multitarget Drug Design Steffen Brunst, Jan S. Kramer, Whitney Kilu, ChemMedChem Drug TargetHit IdentificationLarge Fragment LibraryFragment IdentificationChemical Biology	2020	12
Rh<sup>II</sup>‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors Mikhail Krasavin, Daniil Zhukovsky, Igor V. Solovyev, ChemMedChem	2021	12
Identification of the novel class D β-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus Manuela Tietgen, Jan S. Kramer, Steffen Brunst, Journal of Antimicrobial Chemotherapy	2019	11

Page 1